Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
about
Geranylgeranyl diphosphate synthase: an emerging therapeutic targetIsoprenoids, small GTPases and Alzheimer's disease.Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinicExposure-response relationship of AMG 386 in combination with weekly paclitaxel in recurrent ovarian cancer and its implication for dose selection.Novel clinical trial designs for innovative therapies.Protein farnesylation and disease.Targeting Rho GTPase signaling for cancer therapy.Lonafarnib for cancer and progeria.Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
P2860
Q28252056-8E5FBF98-1483-4548-8C89-052DE38D0E9AQ33915441-F789E065-31E9-4E9C-853F-0FF74A207DE5Q34817365-B2F0F219-CFC8-4346-A338-8F7702F66350Q35914787-24F9B83F-A914-4421-8DEE-6D987156DA82Q37358492-ECFDC24F-28DC-4080-8664-8E3AC3E0834CQ37981563-3A622A16-4D10-47BC-8B49-CF7B71A947E1Q37984123-0939A000-B952-4A83-8716-16C3177E96B3Q38012480-38C2FBA2-4062-47C6-8940-EB79B49E8E47Q54478541-8F045927-7D3E-429B-BCBD-83959DBDE756
P2860
Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@ast
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@en
type
label
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@ast
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@en
prefLabel
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@ast
Phase I pharmacokinetic and ph ...... patients with advanced cancer.
@en
P2093
P2860
P356
P1476
Phase I pharmacokinetic and ph ...... patients with advanced cancer
@en
P2093
G Hoctin-Boes
J H Beijnen
J H M Schellens
J S de Bono
M J Bolijn
M Middleton
N M G M Appels
T C Stephens
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604402
P407
P577
2008-05-27T00:00:00Z